[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352176-105":59,"doc-detail-352176-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","the-prom1smad5-tumor-initiating-subpopulation-shapes-premetastatic-niches-through-spatial-multi-omics-landscapes-in-her2-positive-breast-cancer","The PROM1+SMAD5+ Tumor-Initiating Subpopulation Shapes Premetastatic Niches through Spatial Multi-Omics Landscapes in HER2-Positive Breast Cancer","","The article investigates how PROM1+SMAD5+ breast tumor-initiating cells and their stromal interactions regulate metastatic spread in HER2-positive breast cancer. It applies integrated spatial multi-omics, including spatial transcriptomics, metabolomics, proteomics, exosomal microRNA profiling, and single-nucleus RNA sequencing. Functional in vitro assays, in vivo murine pulmonary metastasis models, parabiosis, and clinical correlation analyses define stromal adipocytes and fibroblasts as key partners shaping premetastatic niches.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-prom1smad5-tumor-initiating-subpopulation-shapes-premetastatic-niches-through-spatial-multi-omics-landscapes-in-her2-positive-breast-cancer/352176/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-prom1smad5-tumor-initiating-subpopulation-shapes-premetastatic-niches-through-spatial-multi-omics-landscapes-in-her2-positive-breast-cancer/352176.png","ImageObject",300,407,{"name":92,"@type":93},"acoobca","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main goal of the study in HER2-positive breast cancer?","Question",{"text":113,"@type":114},"To uncover how breast tumor-initiating cells and stromal subpopulations jointly regulate distant metastasis by reshaping the tumor microenvironment.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which analytical approaches are used to study the tumor and microenvironment?",{"text":118,"@type":114},"The study uses integrated multi-omics with spatial transcriptomics, metabolomics, spatial in situ analysis, and proteomics, complemented by exosomal microRNA and single-nucleus RNA sequencing.",{"name":120,"@type":111,"acceptedAnswer":121},"How do stromal subpopulations influence PROM1+SMAD5+ tumor-initiating cells according to the results?",{"text":122,"@type":114},"The PROM1+SMAD5+ subpopulation is identified along with stromal adipocytes and fibroblasts; these stromal subsets deliver functional microRNAs that mediate COPA-dependent EGFR activation and trigger the EGFR–SMAD5–CYP3A4 axis.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},352176,1790575850,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":26,"preview_page_count":19,"preview_urls":146},3985747870733,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","ORIGINAL ARTICLE  \nThe PROM1+SMAD5+ Tumor-Initiating Subpopulation Shapes Premetastatic Niches through Spatial Multi-Omics Landscapes in HER2-Positive Breast Cancer  \nHuijing Yin1*†, Wei Wang2†, Jing Ge3†, Guangjian Fan1†, Jichao Shi4†, Ye Tian5†, Deping Kong1†, Fanyi Zhang2†, Jing Wei6, Hongrui Zhan7, Zhenyu Xu7, Jintong Ge7, Shuwei Wang7, Zhiming Zhang7, Yunna Zheng7, Zhifa Zhu7, Qingzhen Zi7, Xiaohua Yao7, Yanting Ding7, Bo Song7, Ruizhi Li7, Liming Fan7, Hao Yin7, Yinghao Jiang8, Shaoqian Zhang9, Xingning Fu10, Jing Wang11, Yan Zhou12, Haihua Xue13, Yannan Qiu13, Ling Ge14, Yuqin Yang15, Yinhui Jin15, Binbin Lou16, Shuning Ding2, Tao Zhang17,18, Denghui Wei19*, and Li Zhu2*  \n1Precision Research Center for Refractory Diseases, Institute for Clinical Research, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China. 2Department of General Surgery, ShanghaiGeneral Hospital,ShanghaiJiaoTongUniversitySchoolof Medicine, Shanghai,P. R. China. 3Shanghai Immune Therapy Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China. 4School of Materials Science and Engineering, Shanghai Institute of Technology, Shanghai, P. R. China. 5Core Facility of Basic Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China. 6Becton Dickinson Medical Devices (Shanghai) Co. , Ltd. , Shanghai, P. R. China. 7OE Biotech Co. , Ltd. , Shanghai, P. R. China. 8Shanghai Maihui Biotechnology Co. , Ltd. , Shanghai, P. R. China. 9Akoya Biosciences, Marlborough, MA, USA. 10Department of Pathology, Weifang People’s Hospital, Weifang, Shandong, P. R. China. 11Pathology Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China. 12Central Laboratory, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, P. R. China. 13Accuramed Biotechnology Co. , Limited, Shanghai, P. R. China. 14Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, P. R. China. 15Department of Laboratory Animal Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China. 16Stomatology Department, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China. 17Department of Orthopedic Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China. 18Shanghai Bone Tumor Institution, Shanghai, P. R. China. 19State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, SunYat-sen University Cancer Center, Guangzhou, Guangdong, P. R. China.  \n*[Address correspondence to:](Address correspondence to: yinhuijing_001@163.com)[ yinhuijing_001@163.com](Address correspondence to: yinhuijing_001@163.com) (H.Y.); [weidh@sysucc.org.cn](weidh@sysucc.org.cn) (D.W.); zhuli8@yeah. net (L.Z.)  \n†These authors contributed equally to this work.  \nBackground: Human epidermal growth factor receptor 2 (HER2)-positive breast cancer exhibits high metastatic potential, linked not only to intrinsic cancer cell traits but also to critical crosstalk with the tumor microenvironment. However, the coevolutionary mechanisms between cancer cells and multiplestromal subpopulations in driving distant metastasis remain poorly understood. Therefore, this study aimed to explore the microenvironmental regulatory mechanisms of breast tumor-initiating cells and their roles in HER2-positive breast cancer metastasis. Methods: Integrated multi-omics analyses (spatial transcriptomics, metabolomics, spatial in situ analysis, and proteomics) were used to identify novel cell  \nCitation: Yin H, Wang W, Ge J, FanG, Shi J, TianY, Kong D, Zhang F, Wei J, ZhanH, et al. The PROM1+SMAD5+ Tumor-Initiating Subpopulation Shapes Premetastatic Niches through Spatial Multi-Omics Landscapesin","cbCaitMLRmGULG1m","https://ap.wps.com/l/cbCaitMLRmGULG1m","pdf",19275163,24,"English","# Background\n# Methods\n# Results\n# Citation and Publication Details","[{\"question\":\"What is the main goal of the study in HER2-positive breast cancer?\",\"answer\":\"To uncover how breast tumor-initiating cells and stromal subpopulations jointly regulate distant metastasis by reshaping the tumor microenvironment.\"},{\"question\":\"Which analytical approaches are used to study the tumor and microenvironment?\",\"answer\":\"The study uses integrated multi-omics with spatial transcriptomics, metabolomics, spatial in situ analysis, and proteomics, complemented by exosomal microRNA and single-nucleus RNA sequencing.\"},{\"question\":\"How do stromal subpopulations influence PROM1+SMAD5+ tumor-initiating cells according to the results?\",\"answer\":\"The PROM1+SMAD5+ subpopulation is identified along with stromal adipocytes and fibroblasts; these stromal subsets deliver functional microRNAs that mediate COPA-dependent EGFR activation and trigger the EGFR–SMAD5–CYP3A4 axis.\"}]","The PROM1+SMAD5+ Tumor-Initiating Subpopulation Shapes Premetastatic Niches through Spatial Multi-Omics Landscapes in HER2-Positive Breast Cancer | PDF",1790098135,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb496de4b2831484596c515b12f0685c.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/088e138fce33564a378d0d916b1af978.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8eb2547b17af729b5f94c9486753a74d.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a854cdb71cb9b99d6fb05ef8ec709cfb.webp",980,1306]